YU33880B - Process for preparing estra-1,3,5-(10)-triens oxidized in positions 3 and 17 - Google Patents

Process for preparing estra-1,3,5-(10)-triens oxidized in positions 3 and 17

Info

Publication number
YU33880B
YU33880B YU1125/67A YU112567A YU33880B YU 33880 B YU33880 B YU 33880B YU 1125/67 A YU1125/67 A YU 1125/67A YU 112567 A YU112567 A YU 112567A YU 33880 B YU33880 B YU 33880B
Authority
YU
Yugoslavia
Prior art keywords
triens
estra
oxidized
preparing
positions
Prior art date
Application number
YU1125/67A
Other languages
English (en)
Other versions
YU112567A (en
Inventor
Bertin Daniel
Daniel Bertin
Perdet Andre
Andre Perdet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of YU112567A publication Critical patent/YU112567A/xx
Publication of YU33880B publication Critical patent/YU33880B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU1125/67A 1966-06-07 1967-06-03 Process for preparing estra-1,3,5-(10)-triens oxidized in positions 3 and 17 YU33880B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR64481A FR5519M (de) 1966-06-07 1966-06-07
FR75528A FR1514122A (fr) 1966-06-07 1966-09-07 Dérivés stéroïdes substitués en position 11 à noyau a aromatique et procédé de préparation
FR86879A FR6021M (de) 1966-06-07 1966-12-09
FR91611A FR6030M (de) 1966-06-07 1967-01-18
FR96848A FR6182M (de) 1966-06-07 1967-02-28
FR98154A FR1540942A (fr) 1966-06-07 1967-03-09 Dérivés stéroïdes substitués en positions 11 et 17 à noyau a aromatique et procédé de préparation

Publications (2)

Publication Number Publication Date
YU112567A YU112567A (en) 1977-12-31
YU33880B true YU33880B (en) 1978-06-30

Family

ID=27546052

Family Applications (6)

Application Number Title Priority Date Filing Date
YU1125/67A YU33880B (en) 1966-06-07 1967-06-03 Process for preparing estra-1,3,5-(10)-triens oxidized in positions 3 and 17
YU1758/67A YU33882B (en) 1966-06-07 1967-09-07 Process for preparing estradiol derivatives
YU2408/67A YU33725B (en) 1966-06-07 1967-12-08 Process for preparing 3,17 oxidized esters of1,3,5(10)-trienes
YU109/68A YU34050B (en) 1966-06-07 1968-01-17 Process for preparing 3817beta-dihydroxy-11beta-ethoxy-estra-1,2,3(10)-trienes
YU455/68A YU33883B (en) 1966-06-07 1968-02-27 Process for preparing 3,17-dihydro-11beta-methoxy-17delta-ethinyl-estra-1,3,5-(10)-trienes
YU545/68A YU33972B (en) 1966-06-07 1968-03-08 Process for preparing 3,17beta-dihydroxy-11 beta-ethoxy-17 delta-ethynyl-estra-1,3,5(10)-triene

Family Applications After (5)

Application Number Title Priority Date Filing Date
YU1758/67A YU33882B (en) 1966-06-07 1967-09-07 Process for preparing estradiol derivatives
YU2408/67A YU33725B (en) 1966-06-07 1967-12-08 Process for preparing 3,17 oxidized esters of1,3,5(10)-trienes
YU109/68A YU34050B (en) 1966-06-07 1968-01-17 Process for preparing 3817beta-dihydroxy-11beta-ethoxy-estra-1,2,3(10)-trienes
YU455/68A YU33883B (en) 1966-06-07 1968-02-27 Process for preparing 3,17-dihydro-11beta-methoxy-17delta-ethinyl-estra-1,3,5-(10)-trienes
YU545/68A YU33972B (en) 1966-06-07 1968-03-08 Process for preparing 3,17beta-dihydroxy-11 beta-ethoxy-17 delta-ethynyl-estra-1,3,5(10)-triene

Country Status (14)

Country Link
US (2) US3526648A (de)
AT (3) AT301037B (de)
BE (2) BE699394A (de)
CH (3) CH474495A (de)
DE (1) DE1618830C3 (de)
DK (2) DK121857B (de)
ES (5) ES341435A1 (de)
FR (6) FR5519M (de)
GB (2) GB1151404A (de)
IL (2) IL28112A (de)
NL (2) NL6707903A (de)
SE (2) SE335979B (de)
SU (2) SU483828A3 (de)
YU (6) YU33880B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2140258B1 (de) * 1971-06-07 1974-08-23 Roussel Uclaf
US3906096A (en) * 1971-11-23 1975-09-16 Roussel Uclaf Novel 11{62 -alkoxy steroids
FR2183555B1 (de) * 1972-05-10 1975-06-20 Roussel Uclaf
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
FR2401173A1 (fr) * 1977-06-27 1979-03-23 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4636496A (en) * 1984-03-20 1987-01-13 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4668668A (en) * 1984-03-20 1987-05-26 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
WO2002022645A2 (en) * 2000-09-14 2002-03-21 Accelerated Pharmaceuticals, Inc. Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA3006267C (en) * 2014-11-26 2023-08-29 The Regents Of The University Of California Estrogen receptor modulators
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Also Published As

Publication number Publication date
SU483828A3 (ru) 1975-09-05
YU10968A (en) 1978-05-15
FR5519M (de) 1967-11-06
GB1151404A (en) 1969-05-07
YU33725B (en) 1978-02-28
DE1793738B2 (de) 1975-11-27
AT301037B (de) 1972-08-25
DE1793738A1 (de) 1973-01-11
US3579545A (en) 1971-05-18
YU175867A (en) 1977-12-31
FR6021M (de) 1968-05-13
YU54568A (en) 1978-02-28
GB1152226A (en) 1969-05-14
DE1618830A1 (de) 1972-04-13
NL6707903A (de) 1967-12-08
DE1618829A1 (de) 1971-01-14
ES350987A1 (es) 1969-05-16
DE1618830C3 (de) 1975-02-20
DK119925B (da) 1971-03-15
CH475965A (fr) 1969-07-31
IL28113A (en) 1973-08-29
BE699393A (de) 1967-12-04
FR1540942A (fr) 1968-10-04
US3526648A (en) 1970-09-01
FR6030M (de) 1968-05-13
CH474495A (fr) 1969-06-30
NL6707906A (de) 1968-03-08
ES348057A1 (es) 1969-03-01
YU33972B (en) 1978-09-08
IL28112A (en) 1973-08-29
BE699394A (de) 1967-12-04
FR1514122A (fr) 1968-02-23
YU240867A (en) 1977-08-31
YU33883B (en) 1978-06-30
DE1618830B2 (de) 1974-07-04
YU34050B (en) 1978-10-31
YU112567A (en) 1977-12-31
DK121857B (da) 1971-12-13
SU432714A3 (de) 1974-06-15
AT290023B (de) 1971-05-10
YU45568A (en) 1977-12-31
ES341435A1 (es) 1968-07-01
FR6182M (de) 1968-07-15
ES344805A1 (es) 1968-11-01
SE335979B (de) 1971-06-21
ES351368A1 (es) 1969-06-01
SE335980B (de) 1971-06-21
CH490361A (fr) 1970-05-15
YU33882B (en) 1978-06-30
AT279815B (de) 1970-03-25

Similar Documents

Publication Publication Date Title
YU33880B (en) Process for preparing estra-1,3,5-(10)-triens oxidized in positions 3 and 17
CA953302A (en) 4,4',4''-trihydroxytriphenylmethyl-methane and process for preparing it
IL30663A (en) Polyethylene composition and process for the preparation thereof
IL25635A (en) 2,3-dihydro-5-carboxamido-6-methyl-1,4-oxathiins and methods for the preparation thereof
IL26612A (en) 2-anilino-1,3-diazacyclopentene derivatives and their manufacture
IL32865A0 (en) Erythromycylamine and process for preparing the same
IL27444A (en) Isoxazolo-(5,4-b)-pyridinols and process for their preparation
IL24858A (en) Pyrroloindazoles and process for preparing the same
CY797A (en) 6-trifluoromethyl-tryptophane and process for producing the same
IL25352A (en) 1,2,3-benzoxathiazine 2,2-dioxides and preparation thereof
ZA693639B (en) Benzothiadiazoles and process
YU291770A (en) Process for preparing 4-0-methyldigoxin and 3-0-methyl-digoxin in the pure form
IL25223A (en) Pyridazone derivatives and process for preparing same
IL29949A (en) Diphenyl-pyridazones and process for preparing same
IL38246A (en) 3,5-dioxo-4,5-seco-delta9-steroids and process for preparing same
YU33974B (en) Process for preparing 17 delta-acyloxy-11 beta-methyl-19-norpregn-4-en-3,20-diones and derivatives thereof
CA743143A (en) 1,1-dimethyltetrahydronaphthindans and process for preparing same
IL26911A (en) 1,2-dihydro-1-hydroxy-2-imino-5,6-tri-or 5,6-tetramethylene pyrimidines and process for their preparation
IL26628A (en) 16-oxygenated-20-methyl-pregn-17(20)-en-21-oic acids and 16-oxygenated-17alpha,20-methylene-pregnan-21-oic acids and process for their preparation
CA732173A (en) 3,5-cyclo-6-amino-17-oxygenated-androstanes and process
IL31411A0 (en) Delta4-bufatrienolides substituted in the 3-position,and process for preparing same
CA738993A (en) 6-methyl- and 1,6-dimethyl-ergoline ii derivatives and process for preparing them
IL27389A (en) Substituted 10-aminoalkyl-9,10-dihydroanthracenes and process for preparing same
IL27130A (en) 10-hydroxymethyl-17beta-acyloxy-des-a-delta9,11-gona(estra)-dien-5-ones and their preparation
CA733971A (en) Sulfamyl-3,4-dihydropyrido-1,2,4-thiadiazine-1,1-dioxides and process for their manufacture